Paraclinical evaluation, such as reduced FEV1 and elevated CAT scores, has been identified as an aggravating factor [107], accompanied by laboratory findings of high inflammation factors such as IL1 beta, IFN-γ and IL-2, and TNF, would be present in patients with both COPD and depression [96,97]. This evidence concerns the gene IL2 and depressive disorder.